Literature DB >> 10962481

Flagellar elongation induced by glucose limitation is preadaptive for Trypanosoma cruzi differentiation.

K M Tyler1, D M Engman.   

Abstract

Trypanosomes must sense and respond to environmental change in order to progress through their life cycles. The American trypanosome, Trypanosoma cruzi, differentiates from the noninfective epimastigote form to the infective metacyclic form spontaneously in axenic culture. Here, we investigate the initial stimulus for that change and demonstrate that T. cruzi epimastigotes sense limitation of glucose in the medium and respond by undergoing significant morphological and biochemical change. As part of this change, the mean flagellar length of the population triples, which is correlated with an increased ability to maintain interactions with hydrophobic substrates, a requirement for differentiation to the next life cycle stage. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962481     DOI: 10.1002/1097-0169(200008)46:4<269::AID-CM4>3.0.CO;2-V

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  13 in total

1.  Stationary phase in Trypanosoma cruzi epimastigotes as a preadaptive stage for metacyclogenesis.

Authors:  Roberto Hernández; Ana María Cevallos; Tomás Nepomuceno-Mejía; Imelda López-Villaseñor
Journal:  Parasitol Res       Date:  2012-05-31       Impact factor: 2.289

2.  Flagellar membrane localization via association with lipid rafts.

Authors:  Kevin M Tyler; Alina Fridberg; Krista M Toriello; Cheryl L Olson; John A Cieslak; Theodore L Hazlett; David M Engman
Journal:  J Cell Sci       Date:  2009-02-24       Impact factor: 5.285

3.  Quantitative phosphoproteome and proteome analyses emphasize the influence of phosphorylation events during the nutritional stress of Trypanosoma cruzi: the initial moments of in vitro metacyclogenesis.

Authors:  Aline Castro Rodrigues Lucena; Juliana Carolina Amorim; Carla Vanessa de Paula Lima; Michel Batista; Marco Aurelio Krieger; Lyris Martins Franco de Godoy; Fabricio Klerynton Marchini
Journal:  Cell Stress Chaperones       Date:  2019-07-31       Impact factor: 3.667

4.  Curcumin treatment provides protection against Trypanosoma cruzi infection.

Authors:  Fnu Nagajyothi; Dazhi Zhao; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

5.  Regulation of phosphatidic acid levels in Trypanosoma cruzi.

Authors:  Alba Marina Gimenez; Verónica S Santander; Ana L Villasuso; Susana J Pasquaré; Norma M Giusto; Estela E Machado
Journal:  Lipids       Date:  2011-06-11       Impact factor: 1.880

6.  In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.

Authors:  Adriana M C Canavaci; Juan M Bustamante; Angel M Padilla; Cecilia M Perez Brandan; Laura J Simpson; Dan Xu; Courtney L Boehlke; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

7.  The Trypanosoma cruzi metacyclic-specific protein Met-III associates with the nucleolus and contains independent amino and carboxyl terminal targeting elements.

Authors:  Eva Gluenz; Martin C Taylor; John M Kelly
Journal:  Int J Parasitol       Date:  2006-12-29       Impact factor: 3.981

8.  Mitochondrial Gene Expression Is Responsive to Starvation Stress and Developmental Transition in Trypanosoma cruzi.

Authors:  Aubie K Shaw; Murat C Kalem; Sara L Zimmer
Journal:  mSphere       Date:  2016-04-13       Impact factor: 4.389

9.  Evaluation of high efficiency gene knockout strategies for Trypanosoma cruzi.

Authors:  Dan Xu; Cecilia Pérez Brandán; Miguel Angel Basombrío; Rick L Tarleton
Journal:  BMC Microbiol       Date:  2009-05-11       Impact factor: 3.605

10.  A Novel Method for Inducing Amastigote-To-Trypomastigote Transformation In Vitro in Trypanosoma cruzi Reveals the Importance of Inositol 1,4,5-Trisphosphate Receptor.

Authors:  Muneaki Hashimoto; Jorge Morales; Haruki Uemura; Katsuhiko Mikoshiba; Takeshi Nara
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.